265 related articles for article (PubMed ID: 9675624)
21. Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension.
Angelino PF; Alvino-Demartino A; Mappa R; Donati C
Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):501-5. PubMed ID: 3902676
[TBL] [Abstract][Full Text] [Related]
22. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
[TBL] [Abstract][Full Text] [Related]
23. Vascular effects of chlorthalidone in mild hypertensives.
Bagatin J; Pavlicević I; Sardelić S; Pivac N; Rumboldt Z
Int J Clin Pharmacol Res; 1995; 15(5-6):201-8. PubMed ID: 8835618
[TBL] [Abstract][Full Text] [Related]
24. [Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension].
Herpin D; Guillard O; Piriou A; Amiel A; Boutaud P; Ciber MA; Demange J
Ann Med Interne (Paris); 1988; 139(7):484-7. PubMed ID: 3072894
[TBL] [Abstract][Full Text] [Related]
25. Effects of atenolol and propranolol on platelet aggregation in moderate essential hypertension: randomized crossover trial.
Punda A; Polić S; Rumboldt Z; Bagatin J; Marković V; Lukin A
Croat Med J; 2005 Apr; 46(2):219-24. PubMed ID: 15849842
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
27. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
29. [Bopindolol does not affect normal glucose and lipid metabolism in hypertensive patients].
Fedelesová V; Spustová V; Hucková M; Kovác G
Vnitr Lek; 1989 Sep; 35(9):873-9. PubMed ID: 2573194
[TBL] [Abstract][Full Text] [Related]
30. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
Paran E; Holzberg G; Mazor M; Zmora E; Insler V
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):119-23. PubMed ID: 7757311
[TBL] [Abstract][Full Text] [Related]
31. Ramipril decreases chlorthalidone-induced loss of magnesium and potassium in hypertensive patients.
Simunic M; Rumboldt Z; Ljutic D; Sardelic S
J Clin Pharmacol; 1995 Dec; 35(12):1150-5. PubMed ID: 8750365
[TBL] [Abstract][Full Text] [Related]
32. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
Hermida RC; Ayala DE; Khder Y; Calvo C
Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
[TBL] [Abstract][Full Text] [Related]
33. Antihypertensive effect of oral potassium aspartate supplementation in mild to moderate arterial hypertension.
Franzoni F; Santoro G; Carpi A; Da Prato F; Bartolomucci F; Femia FR; Prattichizzo F; Galetta F
Biomed Pharmacother; 2005; 59(1-2):25-9. PubMed ID: 15740932
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
Derosa G; Cicero AF; Murdolo G; Piccinni MN; Fogari E; Bertone G; Ciccarelli L; Fogari R
Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
[TBL] [Abstract][Full Text] [Related]
35. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
Lee HY; Kang HJ; Koo BK; Oh BH; Heung-Sun K; Kim KS; Seo HS; Ro YM; Kang JH; Woong CJ; Joo SJ; Kim MH; Joon-Han S; Yoon J; Park SH; Jin-Ok J; Ju AK; Chong-Yun R; Yeon KJ; Park KM; Lim DK; Park SY;
Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
[TBL] [Abstract][Full Text] [Related]
36. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
Rakić D; Rumboldt Z; Bagatin J; Polić S
Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
[TBL] [Abstract][Full Text] [Related]
37. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
Pareek A; Basavanagowdappa H; Zawar S; Kumar A; Chandurkar N
Expert Opin Pharmacother; 2009 Jul; 10(10):1529-36. PubMed ID: 19514864
[TBL] [Abstract][Full Text] [Related]
38. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
Sourgens H; Schmidt J; Derendorf H
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
[TBL] [Abstract][Full Text] [Related]
40. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
Rosolová H; Cech J; Sefrna F
Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
